These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy. Windhausen F, Hirsch A, Sanders GT, Cornel J, Fischer J, van Straalen JP, Tijssen JG, Verheugt FW, de Winter RJ, Invasive versus Conservative Treatment in Unstable coronary Syndromes investigators. Am Heart J; 2007 Apr 16; 153(4):485-92. PubMed ID: 17383283 [Abstract] [Full Text] [Related]
5. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Galvani M, Ottani F, Oltrona L, Ardissino D, Gensini GF, Maggioni AP, Mannucci PM, Mininni N, Prando MD, Tubaro M, Vernocchi A, Vecchio C, Italian Working Group on Atherosclerosis, Thrombosis, and Vascular Biology and the Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO). Circulation; 2004 Jul 13; 110(2):128-34. PubMed ID: 15197143 [Abstract] [Full Text] [Related]
6. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome. Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B. J Am Coll Cardiol; 2009 Jul 21; 54(4):357-64. PubMed ID: 19608034 [Abstract] [Full Text] [Related]
8. Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome. Eren NK, Ertaş F, Yüksek U, Cakir C, Nazli C, Köseoğlu M, Ergene O. Turk Kardiyol Dern Ars; 2009 Jan 21; 37(1):1-8. PubMed ID: 19225247 [Abstract] [Full Text] [Related]
16. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction. Björklund E, Jernberg T, Johanson P, Venge P, Dellborg M, Wallentin L, Lindahl B, ASSENT-2 and ASSENT-PLUS Study Groups. Heart; 2006 Jun 21; 92(6):735-40. PubMed ID: 16251228 [Abstract] [Full Text] [Related]
18. Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy. Tang WH, Steinhubl SR, Van Lente F, Brennan D, McErlean E, Maroo A, Francis GS, Topol EJ. Am Heart J; 2007 Jan 21; 153(1):36-41. PubMed ID: 17174634 [Abstract] [Full Text] [Related]